|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-0828-2023 - ETEST CLINICAL MINOCYCLINE MC 256 US S30, CATALOG 412407
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0827-2023 - ETEST CLINICAL MEROPENEM MP 32 US S30, CATALOG 412401
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0826-2023 - ETEST CLINICAL LEVOFLOXACIN LE 32 US S30, CATALOG 412392
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0849-2023 - ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0825-2023 - ETEST CLINICAL IMIPENEM IP 32 US S30, CATALOG 412373
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0824-2023 - ETEST CLINICAL FLUCONAZOLE FL 256 US S30, CATALOG 412333
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0860-2023 - ETEST CLINICAL ETEST VANCOMYCIN VA M100 US, CATALOG 423788
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0852-2023 - ETEST CLINICAL ETEST MEROPENEM/VABORBACTAM MEV US S30, CATALOG 421560
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0859-2023 - ETEST CLINICAL ETEST MEROPENEM MP M100 US, CATALOG 423786
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0823-2023 - ETEST CLINICAL ERYTHROMYCIN EM 256 US S30, CATALOG 412333
|
2
|
01/04/2023
|
Biomerieux Inc
|